Regarding M&A BS: Amarin IMO is not committed to M&A...otherwise they wouldn't be going to these events.
BEDMINSTER, N.J., and DUBLIN, Ireland, March 05, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero, Amarin's president and chief executive officer, is scheduled to present a general company update at Cowen’s 39th Annual Health Care Conference on Wednesday, March 13, 2019, at 8:00 - 8:30 a.m. Eastern Time in Boston.
S:...IMO the Cowen meeting is like the Leerinck meeting...just a "dog and pony" show...while the ACC is like the Kentucky Derby...when Amarin emerges victorious from this meeting, it goes on to be the stock of the year(or of the decade)